O-GlcNAc Modification Is an Endogenous Inhibitor of the Proteasome

Slides:



Advertisements
Similar presentations
Volume 35, Issue 4, Pages (August 2009)
Advertisements

Volume 9, Issue 5, Pages (November 1998)
Volume 11, Issue 6, Pages (June 2003)
Large Hepatitis Delta Antigen Modulates Transforming Growth Factor-β Signaling Cascades: Implication of Hepatitis Delta Virus–Induced Liver Fibrosis 
Volume 6, Issue 3, Pages (September 2000)
Stimulation of V(D)J recombination by histone acetylation
Volume 126, Issue 7, Pages (June 2004)
Nicolas Charlet-B, Gopal Singh, Thomas A. Cooper  Molecular Cell 
Marius K Lemberg, Bruno Martoglio  Molecular Cell 
Volume 23, Issue 6, Pages (December 2005)
Volume 54, Issue 1, Pages (April 2014)
Rapid ubiquitination of Syk following GPVI activation in platelets
Volume 44, Issue 4, Pages (November 2011)
Sp1 Is Required for Glucose-Induced Transcriptional Regulation of Mouse Vesicular Glutamate Transporter 2 Gene  Tao Li, Liqun Bai, Jing Li, Suzu Igarashi,
Volume 22, Issue 5, Pages (May 2012)
Volume 23, Issue 1, Pages (July 2006)
A Mechanism for Inhibiting the SUMO Pathway
Arginine Methylation of STAT1 Modulates IFNα/β-Induced Transcription
Matthew D. Petroski, Raymond J. Deshaies  Molecular Cell 
Volume 6, Issue 6, Pages (March 2014)
Eun-Joo Kim, Jeong-Hoon Kho, Moo-Rim Kang, Soo-Jong Um  Molecular Cell 
Yongli Bai, Chun Yang, Kathrin Hu, Chris Elly, Yun-Cai Liu 
Volume 68, Issue 2, Pages e6 (October 2017)
Volume 11, Issue 1, Pages (January 2003)
Volume 16, Issue 12, Pages (December 2009)
The KSHV Immediate-Early Transcription Factor RTA Encodes Ubiquitin E3 Ligase Activity that Targets IRF7 for Proteosome-Mediated Degradation  Yanxing.
SUMO Promotes HDAC-Mediated Transcriptional Repression
Volume 68, Issue 4, Pages (October 2005)
PARP1 Represses PAP and Inhibits Polyadenylation during Heat Shock
Slicing-Independent RISC Activation Requires the Argonaute PAZ Domain
Volume 93, Issue 5, Pages (May 1998)
Lisheng Ge, Ziqiu Wang, Meifang Wang, Siddhartha Kar, Brian I. Carr 
Increased Ezrin Expression and Activation by CDK5 Coincident with Acquisition of the Senescent Phenotype  Hai-Su Yang, Philip W Hinds  Molecular Cell 
Volume 11, Issue 1, Pages (January 2003)
TNF-Induced Activation of the Nox1 NADPH Oxidase and Its Role in the Induction of Necrotic Cell Death  You-Sun Kim, Michael J. Morgan, Swati Choksi, Zheng-gang.
Volume 66, Issue 4, Pages e5 (May 2017)
Ligand-Independent Recruitment of SRC-1 to Estrogen Receptor β through Phosphorylation of Activation Function AF-1  André Tremblay, Gilles B Tremblay,
Volume 18, Issue 6, Pages (June 2011)
A Role for Ran-GTP and Crm1 in Blocking Re-Replication
Volume 3, Issue 3, Pages (March 2003)
Lysine 63 Polyubiquitination of the Nerve Growth Factor Receptor TrkA Directs Internalization and Signaling  Thangiah Geetha, Jianxiong Jiang, Marie W.
c-Src Activates Endonuclease-Mediated mRNA Decay
Volume 8, Issue 5, Pages (November 2008)
A Critical Role for Noncoding 5S rRNA in Regulating Mdmx Stability
Ken Inoki, Tianqing Zhu, Kun-Liang Guan  Cell 
Ubiquitinated Proteins Activate the Proteasome by Binding to Usp14/Ubp6, which Causes 20S Gate Opening  Andreas Peth, Henrike C. Besche, Alfred L. Goldberg 
Phosphorylation on Thr-55 by TAF1 Mediates Degradation of p53
FAK-Mediated Src Phosphorylation of Endophilin A2 Inhibits Endocytosis of MT1-MMP and Promotes ECM Degradation  Xiaoyang Wu, Boyi Gan, Youngdong Yoo,
Volume 11, Issue 24, Pages (December 2001)
Volume 19, Issue 6, Pages (September 2005)
Volume 26, Issue 6, Pages (June 2007)
Volume 10, Issue 4, Pages (February 2015)
Volume 27, Issue 5, Pages (September 2007)
Rsk1 mediates a MEK–MAP kinase cell survival signal
Volume 31, Issue 6, Pages (September 2008)
Volume 18, Issue 5, Pages (May 2011)
Regulation of the Hippo-YAP Pathway by Glucose Sensor O-GlcNAcylation
Volume 13, Issue 12, Pages (December 2006)
Volume 125, Issue 4, Pages (May 2006)
Hua Gao, Yue Sun, Yalan Wu, Bing Luan, Yaya Wang, Bin Qu, Gang Pei 
Volume 12, Issue 5, Pages (November 2003)
Regulation of Yeast mRNA 3′ End Processing by Phosphorylation
Proteasome-Mediated Degradation of p21 via N-Terminal Ubiquitinylation
Volume 16, Issue 12, Pages (December 2009)
SIRT1 Regulates the Function of the Nijmegen Breakage Syndrome Protein
Phosphorylation of CBP by IKKα Promotes Cell Growth by Switching the Binding Preference of CBP from p53 to NF-κB  Wei-Chien Huang, Tsai-Kai Ju, Mien-Chie.
Mammalian 26S Proteasomes Remain Intact during Protein Degradation
Volume 22, Issue 3, Pages (May 2006)
Doxycycline Indirectly Inhibits Proteolytic Activation of Tryptic Kallikrein-Related Peptidases and Activation of Cathelicidin  Kimberly N. Kanada, Teruaki.
Volume 31, Issue 5, Pages (September 2008)
Presentation transcript:

O-GlcNAc Modification Is an Endogenous Inhibitor of the Proteasome Fengxue Zhang, Kaihong Su, Xiaoyong Yang, Damon B. Bowe, Andrew J. Paterson, Jeffrey E. Kudlow  Cell  Volume 115, Issue 6, Pages 715-725 (December 2003) DOI: 10.1016/S0092-8674(03)00974-7

Figure 1 Generation of GST-SpX from GST-Sp1 (degradation) by Active NE Is Inhibited by GST-OGT (A) Recombinant GST-Sp1 is degraded by activated nuclear extract from NRK cells treated with forskolin and glucose starvation and not degraded by extract from glucosamine-treated cells. (B) GST-Sp1 degradation, assessed by GST Western blot, is inhibited by GST-OGT but not its truncation mutants produced by vaccinia virus. Nucleotide-sugars (5 μM) were added as indicated. (C) GST-Sp1 degradation is inhibited by E. coli-produced GST-OGT. (D) GST-Sp1 degradation is inhibited by His-tagged OGT produced with vaccinia virus. Cell 2003 115, 715-725DOI: (10.1016/S0092-8674(03)00974-7)

Figure 2 O-GlcNAc State of Sp1 Has No Effect on Its Proteasomal Degradation The GST-Sp1 was analyzed by Western blot with the indicated antibodies. (A) Anti-GST blot shows equal loading of GST-Sp1. (B) RL-2 blot shows O-GlcNAc state of GST-Sp1. (C) The indicated preparations of Sp1 were added to activated nuclear extract. The appearance of GST-SpX, the first step in Sp1 degradation, was independent of the starting Sp1 O-GlcNAc level. (D) Degradation of GST-Sp1 with different O-glycosylation levels can all be inhibited by OGT. Cell 2003 115, 715-725DOI: (10.1016/S0092-8674(03)00974-7)

Figure 3 The Proteasome Chymotrypsin-like Peptidase Activity Is Inhibited by OGT Plus UDP-GlcNAc The fluorescence from the cleavage of suc-LLVY-AMC peptide was measured by fluorometry. The graphs show relative fluorescence with 100% occurring in the absence of inhibitor. (A) Chymotrypsin-like peptidase activity in active NRK nuclear extract was inhibited by various proteasome inhibitors (50 μM). (B) Chymotrypsin-like peptidase activity in the active NE was inhibited by GST-OGT and epoxomicin but not inactive OGT truncation mutants. (C) Commassie blue staining of SDS-PAGE 26S proteasome proteins. The proteasomes were purified to the indicated degree. The HP-26S proteasomes were >95% pure. (D) Chymotrypsin-like peptidase activity of 65% pure 26S proteasomes was inhibited by catalytically active GST-OGT. (E) Chymotrypsin-like peptidase activity of 65% pure 26S proteasomes required 5 μM UDP-GlcNAc for inhibition by GST-OGT. (F) Chymotrypsin-like peptidase activity of 20S proteasome core particles was not affected by GST-OGT. Cell 2003 115, 715-725DOI: (10.1016/S0092-8674(03)00974-7)

Figure 4 The Proteasome Trypsin-like Peptidase Activity, Measured by Fluorescence from the Cleavage of boc-LSTR-AMC, Was Not Affected by OGT Plus UDP-GlcNAc Treatment (A) Trypsin-like peptidase activity in the active nuclear extract was not affected by GST-OGT. (B) Trypsin-like peptidase activity of the 26S proteasomes was not affected by GST-OGT. (C) Trypsin-like peptidase activity of the 20S proteasomes was not affected by GST-OGT. Cell 2003 115, 715-725DOI: (10.1016/S0092-8674(03)00974-7)

Figure 5 The ATPase activity of the 26S proteasome was inhibited by OGT (A) Average hydrophobicity score of the proteasome peptide substrates (Sweet and Eisenberg, 1983). (B) The degradation of chymotryptic fluorogenic peptide substrate Z-GGL-AMC by 65% pure 26S proteasome was not affected by OGT treatment. (C) The degradation of chymotryptic fluorogenic peptide substrate Z-GGL-AMC by the active nuclear extract was not affected by OGT treatment. (D) The ATPase activity of 65% pure 26S proteasomes was inhibited by OGT treatment. (E) Chymotrypsin-like peptidase activity of >95% pure 26S proteasomes was inhibited by GST-OGT. (F) The ATPase activity of >95% pure 26S proteasomes was inhibited by OGT treatment. Cell 2003 115, 715-725DOI: (10.1016/S0092-8674(03)00974-7)

Figure 6 Physiologic Role of O-GlcNAc in Proteasome Function (A–C) AMP-PNP inhibited the degradation of LLVY (A), but not that of GGL (B) nor LSTR (C). The fluorescence signal was measured as before. (D) Degradation versus synthesis of GFP-degron in cells cotransfected with OGT siRNA. A net increase in GFP fluorescence was observed in cells cotransfected with OGT siRNA compared to cells cotransfected with a scrambled sequence. When GFP was tagged for proteasome degradation, a net decrease in GFP-degron fluorescence was observed in the OGT siRNA over the scramble transfectants. (E) The degradation of chymotryptic peptide substrate suc-LLVY-AMC by glucosamine inactivated NE was stimulated by GST-O-GlcNAcase. Ten microliters of inactive nuclear extract was pretreated as indicated. After the GST-O-GlcNAcase on beads was removed, the supernatant was treated with or without 50 μM of the indicated proteasome inhibitor and the peptidase activity was measured. (F) Chymotryptic activity of purified proteasomes, inhibited by OGT, can be recovered with O-GlcNAcase. The recovered activity was 35% greater than the starting material. Cell 2003 115, 715-725DOI: (10.1016/S0092-8674(03)00974-7)

Figure 7 Subunits of Pure Proteasomes Including Rpt2 Were Modified by O-GlcNAc (A) Untreated proteasome proteins were resolved by two-dimensional gel electrophoresis and then Western blotted with RL-2. All detectable spots are shown. (B) Proteasomes were treated with OGT and confirmed inactivated (LLVY assay) prior to two-dimensional gel electrophoresis and RL-2 blot. The filled arrow indicates the putative position of Rpt2. (C) The blot in (B) was stripped and reprobed with an Rpt2 antibody. Rpt2 appeared as a close doublet (filled arrow) at the putative position while the other spots vanished (hollow arrow). Shown here is the same area of the gel shown in (A) and (B). (D) Partially purified 26S proteasomes were labeled by OGT, and the protein was resolved by SDS-PAGE and blotted with RL-2. No proteasomes were loaded on lanes 3 and 4. (E) Anti-Rpt2 blot of the stripped membrane from (D). (F) Rpt2 was immunoprecipated from the cell lysates of forskolin- or glucosamine-treatedNRK cells, and the immunoprecipitate was subjected to SDS-PAGE and Western blotting with RL-2. (G) The Western blot, probed for Rpt2, indicates equal amounts of Rpt2 in the lysate. (H) Recombinant GST-Rpt2 is a substrate for OGT in vitro. Recombinant Rpt2 was exposed to OGT plus UDP-GlcNAc, then analyzed by Western blot with RL-2. Cell 2003 115, 715-725DOI: (10.1016/S0092-8674(03)00974-7)